Bristol-Myers Squibb to Take Part in Evercore ISI HealthCONx Conference
NEW YORK--(BUSINESS WIRE)--Nov 20, 2018--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018, in Boston. Johanna Mercier, head of U.S. and Large Markets, Worldwide Commercial, will answer questions about the company at 11:45 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181120005070/en/
Carrie Fernandez, 215-859-2605,firstname.lastname@example.org
Tim Power, 609-252-7509,email@example.com
Bill Szablewski, 609-252-5894,firstname.lastname@example.org
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Bristol-Myers Squibb Company
Copyright Business Wire 2018.
PUB: 11/20/2018 06:59 AM/DISC: 11/20/2018 06:59 AM